Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Markers for Treatment Response to Radiotherapy in Prostate Cancer

NCT06159998 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT06159998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06159998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
Lead sponsor
University of Basel
Phase
Observational
Overall status
Withdrawn
Start date
July 31, 2009
Completion date
July 31, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer